Can a simple vaccine keep COPD patients out of the hospital?
NCT ID NCT07640841
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This large trial will study whether flu and pneumonia vaccines can reduce serious flare-ups and medical costs in people aged 45-80 with COPD. About 7,000 participants will be split into four groups: flu vaccine, pneumonia vaccine, both, or no vaccine. Researchers will track lung function and flare-ups over 12 months to see if vaccination makes a real difference.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Trivalent Influenza Vaccine (inactivated) and 23-valent Pneumococcal Polysaccharide Vaccine
What this could lead to
If successful, this could show that routine flu and pneumonia vaccines help prevent COPD flare-ups and reduce healthcare costs for patients.
What could go wrong
This is a Phase 4 trial, so the vaccines are already approved. The main uncertainty is whether they provide meaningful benefit specifically for COPD patients. The open-label design may introduce bias.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.